ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE

Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva
Médium: Artigo
Jazyk:Russo
Vydáno: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
Edice:Sibirskij Onkologičeskij Žurnal
Témata:
hormone-receptor positive breast cancer
cyclin d1
tamoxifen
resistance mechanisms
On-line přístup:https://www.siboncoj.ru/jour/article/view/1540
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky